LMAT - LeMaitre Vascular Inc Stock Price, Fair Value and News

$84.98+1.30 (+1.55%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

LMAT Price Action

Last 7 days

1.9%

Last 30 days

-2.2%

Last 90 days

-12.4%

Trailing 12 Months

-19.1%

LMAT RSI Chart

LMAT Valuation

Market Cap

1.9B

Price/Earnings (Trailing)

36.15

Price/Sales (Trailing)

EV/EBITDA

24.86

Price/Free Cashflow

26.31

LMAT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

LMAT Fundamentals

LMAT Revenue

Revenue (TTM)

240.9M

Rev. Growth (Yr)

11.36%

Rev. Growth (Qtr)

-4.96%

LMAT Earnings

Earnings (TTM)

53.3M

Earnings Growth (Yr)

55.84%

Earnings Growth (Qtr)

26%

LMAT Profitability

EBT Margin

28.61%

Return on Equity

14.08%

Return on Assets

8.92%

Free Cashflow Yield

3.8%

LMAT Investor Care

Dividend Yield

0.89%

Dividend/Share (TTM)

0.76

Shares Dilution (1Y)

0.90%

Diluted EPS (TTM)

2.31

LMAT Alerts

Big jump in Earnings (Y/Y)

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	226.3M	234.6M	240.9M	0
2024	199.9M	205.6M	213.0M	219.9M
2023	169.2M	177.2M	185.6M	193.5M
2022	158.1M	159.5M	160.2M	161.7M
2021	134.7M	150.5M	152.5M	154.4M
2020	119.3M	114.7M	122.0M	129.4M
2019	108.1M	110.5M	115.5M	117.2M
2018	102.7M	104.0M	103.3M	105.6M
2017	93.0M	96.4M	98.0M	100.9M
2016	79.7M	82.2M	86.3M	89.2M
2015	73.3M	75.0M	76.5M	78.4M
2014	65.9M	68.1M	70.3M	71.1M
2013	58.2M	59.8M	61.4M	64.5M
2012	57.0M	56.3M	55.3M	56.7M
2011	56.8M	57.8M	58.7M	57.7M
2010	0	0	0	56.1M

Get all data in R, Python etc through our Historical Stock Data APIs

About LeMaitre Vascular Inc

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers restoreflow allografts; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access in patients with or without a previously-failed synthetic graft; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

CEO	Mr. George W. LeMaitre
WEBSITE	lemaitre.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	591

LeMaitre Vascular Inc Frequently Asked Questions

What is the ticker symbol for LeMaitre Vascular Inc? What does LMAT stand for in stocks?

LMAT is the stock ticker symbol of LeMaitre Vascular Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of LeMaitre Vascular Inc (LMAT)?

As of Wed Dec 03 2025, market cap of LeMaitre Vascular Inc is 1.93 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LMAT stock?

You can check LMAT's fair value in chart for subscribers.

Is LeMaitre Vascular Inc a good stock to buy?

The fair value guage provides a quick view whether LMAT is over valued or under valued. Whether LeMaitre Vascular Inc is cheap or expensive depends on the assumptions which impact LeMaitre Vascular Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LMAT.

What is LeMaitre Vascular Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, LMAT's PE ratio (Price to Earnings) is 36.15 and Price to Sales (PS) ratio is 8. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LMAT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on LeMaitre Vascular Inc's stock?

In the past 10 years, LeMaitre Vascular Inc has provided 0.183 (multiply by 100 for percentage) rate of return.